Compare Marvell Technology Inc (MRVL) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Marvell Technology Inc trades at $235.62 (market cap $220.43B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Marvell Technology Inc is far larger — about 20.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Marvell Technology Inc for 43 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| MRVL | RDY | |
|---|---|---|
Market Cap | $220.43B | $10.61B |
Volume | 25,874,039 | 3,738,869 |
Sector | Technology | Health |
52-Week High | $316.43 | $15.38 |
52-Week Low | $73.73 | $11.38 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | $221.79B | $10.51B |
Dividend Yield | 0.1% | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marvell Technology (MRVL) trades at $268.73, up 1.08% today, with a bullish technical signal from moving averages and strong analyst support. The company reported three consecutive quarterly EPS beats and projects robust revenue growth, driven by AI and data center demand. Recent news highlights a $120 billion potential deal with Google and raised fiscal 2028 guidance to $18 billion, fueling investor optimism despite high valuation multiples.
Outlook remains positive with a consensus price target of $327.86, implying 22% upside, but risks include elevated P/E of 88.98 and dependence on hyperscaler contracts. Net losses in 2025 contrast with projected 2026 profitability, requiring execution on custom chip growth to justify valuations amid competitive pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
